FLAGSTAFF, Ariz., April 24, 2019 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control,
announces that AB1788, which would ban the use of Second Generation
Anticoagulant Rodenticides (SGARs) has moved another step closer to
becoming law.
California is poised to create
the California Ecosystems Protection Act of 2019 which would
prohibit the use of the four major Second Generation Anticoagulant
Rodenticides (SGARs) commonly used in rodent pest control.
The target problem being addressed in this bill is the
vulnerability of wildlife to the lethality and ecologic persistence
of these SGARs used for rodent control, that have long-term health
impacts on non-target species such as birds of prey, mountain
lions, bobcats, fishers, and endangered species.
"It is becoming clear to us that within the State of California, the demand for more
ecologically sensitive products continues to grow and it is not a
question of 'if,' it is a question of 'when' this legislation
becomes law. The professional pest managers in the State
can bridge this transition by adding ContraPest, our fertility
control flagship product, to their integrated pest management
solution strategies," said Dr. Loretta
Mayer, CEO and co-Founder of SenesTech.
"Meeting the demands of the fifth largest economy in the world
is a challenge that I welcome," said Senior Vice President of
Commercialization, Ed Albe.
"ContraPest is the right product, in the right place, at the right
time. That is why we have chosen to invest our resources into
assuring that Californian's have an alternative solution for this
inevitable event."
The next step for this bill is to go to the California Senate for approval and ultimately
to Governor Newsome for signature. As this process moves
forward SenesTech will continue to serve the wildlife, citizens and
environment of California.
About SenesTech
SenesTech is changing the paradigm of pest management by
targeting the root cause of the problem: reproduction.
ContraPest® is an innovative technology with an
approach that targets the reproductive capabilities of both sexes
in rat populations, inducing egg loss in female rats and impairing
sperm development in males. Using a proprietary bait delivery
method, ContraPest® is dispensed in a highly palatable
liquid formulation that promotes sustained consumption by rat
communities. ContraPest® is designed, formulated and
dispensed to be low hazard for handlers and non-target species such
as wildlife, livestock and pets, where the active ingredients break
down rapidly.
We believe ContraPest® will establish a new paradigm
in rodent control, resulting in a decreased reliance on lethal
options. For more information visit the SenesTech website at
www.senestech.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended
and such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. Forward looking statements include, but are not limited
to, our expectation regarding sales commitments, our expectation
regarding the conversion of sales commitments and programs to
revenue, our belief that our product is more humane, less harmful
to the environment and more effective than traditional methods, and
our belief that ContraPest will establish a new paradigm in rodent
control without environmental effects of rodenticides. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date. We do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:http://www.prnewswire.com/news-releases/california-bill-to-ban-sgar-rodenticides-clears-appropriation-committee-300837640.html
SOURCE SenesTech, Inc.